Phase I evaluation of sequential doxorubicin + gemcitabine then ifosfamide + paclitaxel + cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract Academic Article uri icon

Overview

MeSH Major

  • Antibiotics, Antineoplastic
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Phytogenic
  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Cisplatin
  • Deoxycytidine
  • Doxorubicin
  • Ifosfamide
  • Paclitaxel
  • Urologic Neoplasms

abstract

  • AG is a well-tolerated and active regimen. Sequential chemotherapy with AG-ITP is also well tolerated, and phase II investigation at the highest dose level is ongoing.

publication date

  • February 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10673526

Additional Document Info

start page

  • 840

end page

  • 6

volume

  • 18

number

  • 4